BACKGROUND
B-cell maturation antigen (BCMA), a plasma cell-restricted member of the tumor necrosis factor receptor superfamily, has emerged as the premier immunotherapeutic target in Multiple Myeloma (MM).
METHODS
We performed a comprehensive, comparative review of pivotal Phase II and III clinical trials of BCMA-dir...
Massimo Martino, Erica Bilardi, M. Pitea et al.· European Journal of Haematol...· 0 citations
It is suggested that, within a treosulfan–PTCy platform, major transplant outcomes are comparable between donor types, although haploidentical transplantation was associated with a higher incidence of chronic GVHD.
D. Avenoso, M. Farina, M. Malagola et al.· American journal of hematolo...· 0 citations
How fatigue and other patient-reported symptoms, alongside platelet counts, can inform personalized selection among established and emerging targeted therapies among established and emerging targeted therapies is examined.
M. Martino, L. Giordano, M. Greve et al.· Mediterranean Journal of Hem...· 0 citations
This work provides a robust, high-resolution framework for future genomic epidemiology studies and outbreak investigations of this important emerging fungal pathogen, Magnusiomyces clavatus.
Gabriele Rigano, Letterio Giuffrè, Sebastiano Strangio et al.· Frontiers in Cellular and In...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.